GLPwatch
Papers (10382)
Page 117 of 174, ranked by citation count.
- Semaglutide and Tirzepatide to Treat Obesity.
- Effects of GLP-1 receptor agonists on copeptin in euvolemic participants.
- Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) study.
- Tirzepatide reduces alcohol drinking and relapse-like behaviours in rodents.
- Preparation and evaluation of lactic acid acylated exenatide and its long-acting preparation.
- Long-acting hydrogel-based depot formulations of tirzepatide and semaglutide for the management of type 2 diabetes and weight.
- GLP-1 Receptor Agonists in Breast Cancer: A New Frontier in Obesity and Prognosis Management.
- Patients Are Flocking to Compounded Weight-Loss Drugs, but Are They Safe?
- What Does the Rise of GLP-1 Drugs Mean for Bariatric Surgery?
- Comparative Efficacy of Endoscopic Sleeve Gastroplasty (Esg) Versus Liraglutide in Weight Loss and Remission Of Obesity-Related Comorbidities: Twelve Months Follow-Up Results.
- Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study.
- Weighing in on glucagon-like peptide-1 receptor agonists in dermatology.
- Benefit of insulin glargine/lixisenatide for reducing residual hyperglycaemia in Japan: Post hoc analysis of the LixiLan JP-O2 trial.
- Long-term effects of adding exenatide to a regimen of metformin and/or sulfonylurea in type 2 diabetes: an uncontrolled, open-label trial in Hungary.
- Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial.
- Improvement in body mass index category was associated with improved cardiometabolic measures and patient-reported outcomes in adults with type 2 diabetes treated with tirzepatide.
- Effect of Tirzepatide Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes Mellitus.
- Exenatide improves hepatocyte insulin resistance induced by different regional adipose tissue.
- Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonists as a promising strategy for treating diabetes.
- GLP-1 and amylin receptor multiagonism with amycretin for obesity management.
- Effect of incretin-based therapies on blood pressure: a systematic review and meta-analysis.
- New antihyperglycaemic agents and cardiovascular disease: let's be optimistic.
- Combination exenatide-sitagliptin therapy used with glipizide in a patient with type 2 diabetes mellitus.
- Glucagon-like Peptide-1 Receptor Agonists: Exciting Avenues Beyond Weight Loss.
- The Influence of Liraglutide for Heart Failure: A Meta-Analysis of Randomized Controlled Trials.
- The mechanistic role of tirzepatide in atherosclerosis: A review.
- Patient and public involvement and engagement in the ASCEND PLUS trial: reflections from the design of a streamlined and decentralised clinical trial.
- Tirzepatide Induces Ferroptosis in Glioblastoma Cell Lines via the SOX2/SLC7A11 Axis: A Potential Therapeutic Strategy for Glioma Treatment.
- Patient Experience of Treatment with Tirzepatide for Weight Management: Exit Interviews from SURMOUNT-4.
- Exenatide ER-induced eosinophilia.
- After 10 Years of Clinical Trials with Liraglutide in Diabetes, What do we Know About its Effects on Clinical Cardiovascular Outcomes?
- Efficacy and tolerability of GLP-1 agonists in patients with type 2 diabetes mellitus: an Indian perspective.
- Pre-pregnancy treatment of semaglutide improves high-fat-diet-induced placental and fetal hypothalamic alterations in a sex-specific manner in rats†.
- Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.
- Exenatide once weekly in type 2 diabetes mellitus.
- A Pharmacological Dose of Liraglutide Improves Mitochondrial Performance in Mouse Leydig Cells.
- Liraglutide (Victoza) for type 2 diabetes.
- Switching From Daily DPP-4 Inhibitor to Once-Weekly GLP-1 Receptor Activator Dulaglutide Significantly Ameliorates Glycemic Control in Subjects With Poorly Controlled Type 2 Diabetes Mellitus: A Retrospective Observational Study.
- Liraglutide and learning.
- A single-center study on the biochemical effect and clinical effectiveness of liraglutide in Turkish patients.
- Unraveling the safety profile of GLP-1 receptor agonists: Mechanistic insights with a focus on semaglutide.
- First fixed-ratio combination of insulin degludec and liraglutide for the treatment of type 2 diabetes.
- Comparative evaluation of dulaglutide alone vs. dulaglutide combined with probiotics on cardiovascular risk factors in T2DM.
- Potential Role of Hypothalamic and Plasma Ghrelin in the Feeding Behavior of Obese Type 2 Diabetic Rats with Intraventricular Glucagon-Like Peptide-1 Receptor Agonist Intervention.
- Systematic Review and Meta-Analysis of the Efficacy and Safety of Metformin and GLP-1 Analogues in Children and Adolescents with Diabetes Mellitus Type 2.
- Gut microbiota perturbation and systemic inflammation are associated with salcaprozate sodium (SNAC)-enabled oral semaglutide delivery.
- The combination of a glucagon-like peptide-1 and amylin receptor agonists reduces alcohol consumption in both male and female rats.
- Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.
- Prevalence of normal coronary arteries by coronary computed tomography angiography (CCTA) in patients with type 2 diabetes mellitus from Semaglutide Treatment on Coronary Plaque Progression (STOP) trial.
- A novel antihypertensive effect of exenatide, a GLP-1 agonist.
- Incretin-based therapies in clinical practice: from efficacy to effectiveness. Focus on liraglutide.
- Treatment of obese diabetics.
- Clinical Efficacy of Once-weekly Glucagonlike Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes.
- Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes.
- Evaluation of the Use of Exenatide Once-Weekly Suspension Autoinjector Among Patients With Type 2 Diabetes Mellitus and Health Care Professionals.
- Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice.
- A Revolution in the Treatment of Obesity.
- Unraveling the impact of semaglutide in a diabetic rat model of testicular dysfunction: Insights into spermatogenesis pathways and miRNA-148a-5p.
- GLP-1 receptor agonists: fighting obesity with an eye to cardiovascular risk.
- Publicising trial results before peer review.